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Abstract: In a recent study, we investigated the antimicrobial activity of a collection of resveratrol-derived
monomers and dimers against a series of foodborne pathogens. Out of the tested molecules,
dehydro-δ-viniferin and dehydro-ε-viniferin emerged as the most promising derivatives. To define
the structural elements essential to the antimicrobial activity against the foodborne pathogen
L. monocytogenes Scott A as a model Gram-positive microorganism, the synthesis of a series of
simplified benzofuran-containing derivatives was carried out. The systematic removal of the aromatic
moieties of the parent molecules allowed a deeper insight into the most relevant structural features
affecting the activity. While the overall structure of compound 1 could not be altered without
a substantial loss of antimicrobial activity, the structural simplification of compound 2 (minimal
inhibitory concentration (MIC) 16 µg/mL, minimal bactericidal concentration (MBC) >512 µg/mL) led
to the analogue 7 with increased activity (MIC 8 µg/mL, MBC 64 µg/mL).
Keywords: viniferin derivatives; benzofuran nucleus; antimicrobials; Listeria monocytogenes
1. Introduction
Benzofuran derivatives are an important class of heterocyclic compounds, occupying a place in
numerous bioactive natural products. Over time, they have attracted the attention of many researchers
due to the broad scope of their activity, which includes anticancer, antimicrobial, immunomodulatory,
antioxidant and anti-inflammatory properties [1,2].
In recent years, the benzofuran scaffold has emerged as a pharmacophore of choice for designing
antimicrobial agents, and numerous achievements have revealed that benzofuran-based compounds
have an extensive potential in this field [3].
As a part of our efforts in the search for new antimicrobial agents, we have recently evaluated the
antimicrobial activity of a collection of resveratrol-derived monomers (e.g., resveratrol, pterostilbene)
and dimers (e.g., trans-δ-viniferin, trans-ε-viniferin, dehydro-δ-viniferin 1, viniferifuran 2), which were
screened as single molecules against a panel of foodborne pathogens (Figure 1) [4].
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Figure 1. Structures of resveratrol and representative resveratrol-derived monomers and dimers. 
The most promising dimeric compound, dehydro-δ-viniferin 1, was endowed with significant 
antibacterial activity against Gram-positive bacteria. It was verified that the activity of 1 against L. 
monocytogenes was achieved by damaging the cytoplasmic membrane with significant membrane 
depolarization, a loss of membrane integrity, and severe morphological changes. The dimeric 
compound 2 showed significant antimicrobial activity as well [4]. 
These promising results prompted us to explore 1 and 2 as platforms in the search for new 
antimicrobial scaffolds. To provide a deeper insight into the activity of these compounds, we planned 
to perform preliminary structure–activity relationship (SAR) studies. The unique structural features 
of compounds 1 and 2, both containing a versatile benzofuran core structure, make them amenable 
for the generation of differently substituted analogues. To shed light on the minimal structural 
features which retain antimicrobial activity, we designed a small collection of simplified derivatives 
of compounds 1 and 2 by a systematic removal of the moieties linked to the benzofuran rings (groups 
A, B, C) (Figure 2), and we tested all the derivatives against Listeria monocytogenes as a representative 
foodborne Gram-positive bacterium, which was found to be sensitive to compounds 1 and 2 [4].  
Figure 1. Structures of resveratrol and representative resveratrol-derived monomers and dimers.
The most promising dimeric compound, dehydro-δ-viniferin 1, was endowed with significant
antibacterial activity against Gram-positive bacteria. It was verified that the activity of 1 against
L. monocytogenes was achieved by damaging the cytoplasmic membrane with significant membrane
depolarization, a loss of membrane integrity, and severe morphological changes. The dimeric compound
2 showed significant antimicrobial activity as well [4].
The e promi ing results pro pted us to explore 1 and 2 as platforms in the search for new
antimicrobial scaffolds. To provide a deeper insight into the activity of these compounds, we planned
to perform preliminary structure–activity relationship (SAR) studies. The unique structural features of
compounds 1 and 2, both containing a versatile benzofuran core structure, make them amenable for the
generation of differently substituted analogues. To shed light on the minimal structural features which
retain antimicrobial activity, we designed a small collection of simplified derivatives of compounds
1 and 2 by a systematic removal of the moieties linked to the benzofuran rings (groups A, B, C)
(Figure 2), and we tested all the derivatives against Listeria monocytogenes as a representative foodborne
Gram-positive bacterium, which was found to be sensitive to compounds 1 and 2 [4].
Therefore, we designed the three possible simplified analogues of compound 1 (compounds 3–5)
and the three sibl simplified analogues of compound 2 (compounds 6–8) (Fig re 2). In a dition,
we designed three representative analogues (9–11) containing the -OMe groups in place of the phenolic
-OH on the aromatic rings.
The evaluation of the antimicrobial activity of the compounds provided an integrated overview of
the structural determinants for the activity against the foodborne pathogenic species L. monocytogenes
Scott A.
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2. Results 
In the present SAR study, different synthetic approaches were set up depending on the nature 
of the benzofuran substitution pattern.  
Initially, we focused on the synthesis of the simplified analogues of compound 1. Compound 14 
was obtained by a Cu-catalyzed tandem Sonogashira coupling–cyclization reaction starting with 2-
iodophenol 12 and 1-ethynyl-4-methoxybenzene 13 [5,6]. The iodination of 14 with NIS gave 
compound 15 in a 74% yield [7]. Suzuki coupling of 15 with (3,5-dimethoxyphenyl)boronic acid gave 
the permethylated intermediate 16, which, after the deprotection of the phenolic -OH with BBr3, 
afforded 2,3-disubstituted benzofuran 3 (Scheme 1). 
Figure 2. Structures of compounds 1 and 2 and of the simplified analogues 3–8 and 9–11.
2. Results
In the present SAR study, different synthetic approaches were set up depending on the nature of
the benzofuran substitution pattern.
Initially, we focused on the synthesis of the simplified analogues of compound 1. Compound
14 was obtained by a Cu-catalyzed tandem Sonogashira coupling–cyclization reaction starting with
2-iodophenol 12 and 1-ethynyl-4-methoxybenzene 13 [5,6]. The iodination of 14 with NIS gave
compound 15 in a 74% yield [7]. Suzuki coupling of 15 with (3,5-dimethoxyphenyl)boronic acid
gave the permethylated intermediate 16, which, after the deprotection of the phenolic -OH with BBr3,
afforded 2,3-disubstituted benzofuran 3 (Scheme 1).Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 10 
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°C, 40 min; ii) ACN, 100 °C, 90 min, 50%; b) NIS, p-TsOH, ACN, N2, overnight, 74%; c) (3,5-
dimethoxyphenyl)boronic acid, K2CO3, PdCl2(dppf)·CH2Cl2, THF:H2O 1:1, MW, 70 °C, 30 min, 83%; 
d) BBr3, DCM, 0 °C to rt, overnight, 61%. 
The synthesis of compound 4 was based on the same key Cu-catalyzed tandem Sonogashira 
coupling-cyclization described above for the construction of the 2-aryl-substituted benzofuran ring 
(Scheme 2). However, in this case the iodophenol should have a suitable moiety in position 4 to install 
the styryl functionality. Thus, compound 17 was reacted with 13 to obtain the ester 18, which was 
then converted into the corresponding aldehyde 19 by an LiAlH4 reduction, followed by a Dess–
Martin periodinane oxidation. A Wittig–Horner olefination with diethyl (3,5-
dimethoxyphenyl)phosphonate under microwave irradiation afforded 10. The final deprotection step 
of all the phenol groups was quite troublesome. Previous works reported that the demethylation of 
the stilbenoid derivatives was achieved using BBr3 in CH2Cl2 [8]. However, when applying these 
conditions to compound 10, only the partially demethylated compound 9 was obtained. We, 
therefore, decided to explore the alternative route reported by Vo et al. [9], based on the use of boron 
trichloride/tetra-n-butylammonium iodide (BCl3/TBAI). Actually, the reagent was found to be more 
effective than boron tribromide and allowed us to obtain the demethylated compound 4. A semi-
preparative HPLC purification was required to obtain the pure compound in a 35% yield. 
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°C, 40 min; ii) ACN, 100 °C, 90 min, 62%; b) i) LiAlH4, THF, N2, 0 °C, 10 min; ii) DMP, DCM, 0 °C 15 
min, rt 90 min, 85%; c) diethyl (3,5-dimethoxyphenyl)phosphonate, NaH, THF, MW, 120 °C, 30 min, 
76%; d) BBr3, DCM, 0 °C to rt, overnight, 60%; e) BCl3, TBAI, DCM, N2, 0 °C to rt, 6h, 35%. 
The functionalization of positions 3 and 5 of the benzofuran ring required a different synthetic 
approach (Scheme 3). The heterocyclic core was synthesized efficiently from 20 by the sequence of 
alkylation with bromoacetaldehyde dimethylacetal and cyclodehydration using Amberlyst-15, 
following a procedure described by Liu et al. [10]. The introduction of a bromine in position 3 was 
obtained by the bromination of 22 followed by a treatment with KOH in MeOH [11]. The Suzuki 
coupling of compound 24 with (3,5 dimethoxyphenyl) boronic acid afforded compound 25. LiAlH4 
reduction followed by a Dess–Martin periodinane oxidation gave the aldehyde 26, which underwent 
a Wittig–Horner olefination with diethyl(3,5-dimethoxyphenyl)phosphonate under microwave 
irradiation at 120 °C to give compound 27. Again, the critical step was the final deprotection of the 
Scheme 1. Reagents and conditions: (a) (i) PdCl2(PPh3)2 (5% mol), CuI (3% mol), TEA:THF 1:1,
N2, 40 ◦C, 40 min; (ii) ACN, 100 ◦C, 90 min, 50%; (b) NIS, p-TsOH, ACN, N2, overnight, 74%; (c)
(3,5-dimethoxyphenyl)boronic acid, K2CO3, PdCl2(dppf)·CH2Cl2, THF:H2O 1:1, MW, 70 ◦C, 30 min,
83%; (d) BBr3, DCM, 0 ◦C to rt, overnight, 61%.
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The synthesis of compound 4 was based on the same key Cu-catalyzed tandem Sonogashira
coupling-cyclization described above for the construction of the 2-aryl-substituted benzofuran ring
(Scheme 2). However, in this case the iodophenol should have a suitable moiety in position 4 to install
the styryl functionality. Thus, compound 17 was reacted with 13 to obtain the ester 18, which was then
converted into the corresponding aldehyde 19 by an LiAlH4 reduction, followed by a Dess–Martin
periodinane oxidation. A Wittig–Horner olefination with diethyl (3,5-dimethoxyphenyl)phosphonate
under microwave irradiation afforded 10. The final deprotection step of all the phenol groups was
quite troublesome. Previous works reported that the demethylation of the stilbenoid derivatives was
achieved using BBr3 in CH2Cl2 [8]. However, when applying these conditions to compound 10, only
the partially demethylated compound 9 was obtained. We, therefore, decided to explore the alternative
route reported by Vo et al. [9], based on the use of boron trichloride/tetra-n-butylammonium iodide
(BCl3/TBAI). Actually, the reagent was found to be more effective than boron tribromide and allowed
us to obtain the demethylated compound 4. A semi-preparative HPLC purification was required to
obtain the pure compound in a 35% yield.
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Scheme 2. Reagents and conditions: (a) (i) PdCl2(PPh3)2 (5% mol), CuI (3% mol), TEA:THF 1:1, N2,
40 ◦C, 40 min; (ii) ACN, 100 ◦C, 90 min, 62%; (b) (i) LiAlH4, THF, N2, 0 ◦C, 10 min; (ii) DMP, DCM, 0 ◦C
15 min, rt 90 min, 85%; (c) diethyl (3,5-dimethoxyphenyl)phosphonate, NaH, THF, MW, 120 ◦C, 30 min,
76%; (d) BBr3, DCM, 0 ◦C to rt, overnight, 60%; (e) BCl3, TBAI, DCM, N2, 0 ◦C to rt, 6 h, 35%.
The functionaliza ion of posit ons 3 and 5 of the benzofuran ring required a different synthetic
approach (Scheme 3). The heterocyclic core was synthesized efficiently from 20 by the sequence
of alkylation with bromoacetaldehyde dimethylacetal and cyclodehydration using Amberlyst-15,
following a procedure described by Liu et al. [10]. The introduction of a bromine in position
3 was obtained by the bromination of 22 followed by a treatment with KOH in MeOH [11].
The Suzuki coupling of compound 24 with (3,5 dimethoxyphenyl) boronic acid afforded compound
25. LiAlH4 reduction followed by a Dess–Martin periodinane oxidation gave the aldehyde 26,
which unde went a Wittig–Horner o efination with di thyl(3,5-dimethoxyphenyl)phosphonate under
microwave irradiation at 120 ◦C to give compound 27. Again, the critical step was the final deprotection
of the phenolic groups. After several attempts, compound 5 was obtained in a 14% yield by a treatment
with BBr3 and a troublesome purification by flash chromatography.
Successively, we focused on the analogues of compound 2. Kim and Choi [12] employed a versatile
and mild procedure to construct a 3-arylbenzofuran by the cyclization of the corresponding β-aryloxyketone
using Bi(OTf)3. Following this protocol, compound 30 was prepared by the reaction of m-methoxyphenol
with the α-bromoketone 29, on its turn obtained by treatment of 3,5-dimethoxyacetophenone 28 with
CuBr2. The β-aryloxyketone 30 was subjected to a cyclodehydration reaction with Bi(OTf)3, involving
an intramolecular Friedel–Craft acylation followed by dehydration to give the desired benzofuran 31.
The same synthetic protocol was applied to the ketone 32 to obtain the benzofuran 33. In both cases, the
intramolecular cyclization took advantage of the presence of the electron-donating OMe group.
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The installation of a further aromatic ring on the C-2 of compound 31 was obtained by direct
arylation by using Pd(OAc)2 and P(Cy)3·HBF4 [13]. The deprotection of the derivative 11 with BBr3
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Scheme 4. Reagents and conditions: (a) CuBr2, EtOAc:CHCl3, reflux, overnight, 67%; (b) m-methoxyphenol,
K2CO3, acetone, N2, reflux, 2 h, 90%; (c) Bi(OTf)3, DCM, N2, reflux, overnight, 43%; (d) p-methoxybromobenzene,
Pd(OAc)2, PCy3HBF4, K2CO3, pivalic acid, DMA, N2, 100 ◦C, 20 h, 80%; (e) BBr3, DCM, 0 ◦C to rt, overnight,
52%; (f) 3-bromo-5-methoxyphenol, K2CO3, acetone, N2, reflux, 2 h, 89%; g) Bi(OTf)3, DCM, N2, reflux, overnight,
83%; (h) BBr3, DCM, 0 ◦C to rt, overnight, 91%; (i) p-hydroxystyrene, Pd(OAc)2, TEA, dppp, DMF, N2, 120 ◦C,
20 h, 80%.
Conversely, to obtain compound 7, it was necessary to introduce the styryl moiety in position
4. To avoid the formation of side products due to the reactivity of the styryl double-bond with the
deprotecting reagent, we first treated compound 33 with BBr3 to afford compound 34 in a 91% yield.
Finally, a Heck coupling with pOH styren gave th desir d scaffo d 7.
The last implified analogue was ob ained as reported in Scheme 5. Compound 35 was methylated
to give compound 36, following the procedure described by Iino [14]. However, in our study, the selective
methylation reaction also gave 40% of a dialkoxy compound, which needed to be separated by column
chromatography. The benzofuran derivative 38 was then obtained by the sequence of alkylation with
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bromoacetaldehyde dimethylacetal and cyclodehydration using Amberlyst-15, as described before.
A treatment with NBS afforded 2-bromobenzofuran 39, which was isolated in a high yield as the only
isomer when we used dichloroethane as the solvent and DMF as the catalyst, as described by Liu [10].
A Suzuki coupling followed by the conversion of the ester group into aldehydes, as previously reported,
led to compound 41, which was then subjected to an olefination reaction to give compound 42. Finally,
the deprotection of the -OMe groups gave the simplified compound 8.
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The synthesized molecules 1–11 were tested against the foodborne pathogen L. monocytogenes
Scott A, after being recognized as one of the most sensitive species as a result of our previous
screening [4]. The results are reported in Table 1. The minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC) values confirmed the higher sensitivity of L. monocytogenes
to compound 1 (MIC 2 µg/mL, MBC 16 / ) rather than to compound 2 (MIC 16 µg/mL, MBC
>512 µg/mL). In general, the struct ral modifications of compounds 1 and 2 negativel i with
their antimicrobial activity (Table 1). However, compound 7, a simplified analogue of compound 2,
showed an evident decrease in its MIC (8 µg/mL) and MBC (64 µg/mL) values, reflecting an improved
antimicrobial activity.
Table 1. Antimicrobial activity of synthesized compounds against L. monocytogenes Scott A a and
cytotoxic activity on WS1 b.
Compound L. monocytogenesScott A
L. monocytogenes
Scott A WS1
MIC (MBC) µg/mL a MIC (µM) a IC50 (µM) b
resveratrol 200 (-) c 876 >200
pterostilbene 64 (128) 250 57 ± 10
1 dehydro-δ-viniferin 2 (16) 4.42 37.0 ± 1.4
2 viniferifuran 16 (>512) 35.4 33.0 ± 1.4
3 16 (64) 50.3 98.7 ± 1.8
4 256 (>512) 743 97.8 ± 3.0
5 16 (64) 44.4 96.8 ± 4.5
6 64 (>512) 191 98.5 ± 2.0
7 8 (64) 23.2 45.0 ± 1.2
8 64 (>512) 178 85.0 ± 4.6
9 >512 (>512) 1370 95.0 ± 2.3
10 >256 (>256) 662 >100
11 >256 (>256) 656 >100
Chlorhexidine 8 (32) 15.8 -
a MIC is the minimal inhibitory concentration inhibiting the growth; MBC (in brackets) is the minimal bactericidal
concentration. b IC50 is defined as the concentration of compound causing 50% cell growth inhibition. Twenty-four
hours after seeding, cells were exposed for 48 h to the compounds and cytotoxicity was measured using MTS assay.
Data represent mean values ± SD of three independent experiments. c L. monocytogenes LMG 16,779 [15].
Int. J. Mol. Sci. 2020, 21, 2168 7 of 10
3. Discussion
The rapid development of the resistance of bacterial pathogens against antimicrobial agents
still represents an important problem [16,17]. To overcome this drawback, the identification and
development of novel scaffolds is imperative.
Stilbenoids are an intriguing structural class of natural polyphenols characterized by a diverse
array of biological properties [18]. Among stilbenoids, resveratrol and the dimethyl derivative
pterostilbene have shown promising antimicrobial activity [19,20].
Recently, we investigated a focused collection of resveratrol-derived compounds, including
resveratrol-derived monomers and dimers, which were screened against a series of foodborne
pathogens [4]. The collected evidence indicated that most of the compounds were endowed with a
significant antimicrobial activity against Gram-positive bacteria, with 1 and 2 being the most potent
molecules of the series.
To shed light on the SAR of these compounds, and to understand whether structural modifications
could be exploited in the development of more potent congeners, we synthesized the simplified
derivatives of 1 and 2. Importantly, the selective removal of the aromatic rings from compound 1′s
skeleton significantly reduced antimicrobial activity. In fact, compared to the parent compound 1, the
derivatives 3, 4 and 5, obtained from the removal of the moieties in positions 5, 3 and 2, respectively,
had significantly lower activity. In particular, the removal of the ring B (derivative 4), resulted in a
completely inactive compound (MIC 256 µg/mL, MBC >512 µg/mL). This finding suggests that the
three phenolic portions A, B, and C present in the parent compound 1 are all important and synergic
for antimicrobial activity.
Conversely, SAR studies on the analogues of compound 2 showed that the removal of the ring B
increased the activity of the derivative. Indeed, compound 7 was more potent than 2 (MIC 8 µg/mL,
MBC 64 µg/mL vs. MIC 16 µg/mL, MBC >512 µg/mL), whereas compounds 6 and 8, obtained by
the selective removal of the moieties C and A, respectively, showed four-fold lower activity, only in
terms of MIC, compared to the parent compound 2 (MIC 64 µg/mL vs. 16 µg/mL). It is interesting to
notice that the most active compound of this series, compound 7, has three phenolic portions with a
spatial orientation similar to that of compound 1. Interestingly, the introduction of a hydroxy group
on the benzofuran skeleton of compound 3 (6 vs. 3), caused a four-fold reduction in activity (MIC
64 µg/mL, MBC >512 µg/mL vs. MIC 16 µg/mL, MBC 64 µg/mL). The replacement of the phenolic
hydroxyl groups with the methoxy groups was, in any case, deleterious, giving inactive compounds
(compounds 9, 10, 11). Notably, not only the spatial orientation but also the distance between the
substituents of the rings seemed to play a role. In fact, compound 9 differed from pterostilbene only in
a longer spacer connecting the two substituted rings (the benzofuran core). This difference results in a
drop in compound activity (MIC and MBC >512 µg/mL vs. MIC 64 µg/mL, MBC 128 µg/mL).
Overall, the results confirm that the shape and geometry of the molecules play a key role in
the antimicrobial activity. Indeed, it is well documented that the hydroxy groups in polyphenolic
compounds can interact with the bacterial cell membrane [21,22], and that the relative position of the
-OH groups on the phenolic nucleus strongly influences the antibacterial efficacy [23,24].
To evaluate the potential toxicity of the compounds on healthy human cells, the antiproliferative
activity of the synthesized molecules, together with the natural compounds resveratrol and pterostilbene,
was evaluated on normal skin fibroblast WS1 cells (Table 1). The concentration of compound causing
50% cell growth inhibition (IC50) of resveratrol was > 200 µM, whereas the IC50 of all the other
compounds ranged from 33 to >100 µM. A comparison with the MIC of the compounds against
L. monocytogenes Scott A (µM concentration, Table 1) showed that 1 has a very good profile of selectivity.
Indeed, cytotoxic effects were observed at a concentration ~10-fold higher than the lowest concentration
of the compound that prevents the visible growth of bacteria. Moreover, the simplified analogues 3, 5,
7 displayed cytotoxic activity in a range of concentration two-fold higher than the MIC values.
Overall, the collected data identified the scaffolds of compounds 1 and 7 as the most promising
for further developments.
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4. Materials and Methods
4.1. Chemical Synthesis
The procedures for the synthesis and characterization data for the various derivatives and
intermediates are detailed in the Supplementary Materials.
4.2. Evaluation of the Minimal Inhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC)
All synthesized derivatives were stored in dry form at −20 ◦C and dissolved in DMSO at a
final concentration of 4.096 mg/mL prior to their use in the MIC and MBC determination. Briefly,
L. monocytogenes was cultivated in Brain Hearth Infusion (BHI) broth (Sigma, Italy) at 37 ◦C for 24 h
under a shaking condition (200 rpm). After the growth, the cells were diluted in BHI to 0.2 OD 600
nm and then used for the 96-well plate inoculum. The concentrations tested ranged from 1 up to 512
µg/mL. The assay was carried out in triplicate in a 96-well plate, according to Mattio et al., 2019 [4].
4.3. Cytotoxicity on Human Skin Normal WS1 Fibroblast Cells
The normal human skin WS1 fibroblast cells (ATCC CRL-1502) were cultured in Eagle’s Minimum
Essential Medium plus 10% fetal bovine serum at 37 ◦C and 5% CO2.
Cytotoxic potency was assessed by a growth inhibition assay (CellTiter 96® AQueous One Solution
Cell Proliferation Assay MTS, Promega). The cells were seeded in a 96-well plate, and 24 h later
were exposed to the compounds (concentration range 1−200 µM). After 48 h of exposure, 20 µL
of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt
was added to each well. The absorbance was measured using a FLUOstar OPTIMA plate reader
(BMG Labtech GmbH, Offenburg, Germany) at 492 nm after 4 h of incubation at 37 ◦C in 5% CO2.
The IC50 was defined as the drug concentration causing 50% cell growth inhibition, determined by the
dose−response curves. Experiments were performed in triplicate.
5. Conclusions
In the present study, we gained further insight into the properties of the viniferin analogues
and reported the structural requirements which are fundamental in the antimicrobial activity of the
derivatives 1 and 2. Moreover, we showed that, although less active than the parent compound 1,
the simplified derivatives 3 and 5 retained antimicrobial activity. In addition, we were pleased to find
that the simplification strategy adopted for compound 2 was successful. Indeed, compound 7, which
showed two-fold higher potency compared with 2, represents an intriguing new versatile scaffold for
further derivatization.
The cytotoxic profile observed on normal human cells was interesting. Indeed, on the WS1
fibroblasts, compounds 1, 3, 5, 7 showed cytotoxic effects at concentrations at least two-times higher
than that observed on Listeria monocytogenes. Among these, compound 1 resulted as the most selective
of the series.
In conclusion, this study identified dehydro-δ-viniferin 1 and compound 7 (the simplified derivative
of viniferifuran 2) as promising scaffolds for the development of nature-inspired antimicrobials active
against foodborne pathogenic species.
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